Millennium Management LLC Increases Stock Holdings in 908 Devices Inc. (NASDAQ:MASS)

Millennium Management LLC increased its position in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) by 35.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 618,310 shares of the company's stock after buying an additional 161,922 shares during the period. Millennium Management LLC owned about 1.79% of 908 Devices worth $3,184,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. GAMMA Investing LLC purchased a new position in 908 Devices in the second quarter valued at approximately $48,000. State Board of Administration of Florida Retirement System purchased a new position in 908 Devices in the first quarter valued at approximately $80,000. American Century Companies Inc. increased its stake in 908 Devices by 18.6% in the second quarter. American Century Companies Inc. now owns 33,718 shares of the company's stock valued at $174,000 after purchasing an additional 5,295 shares during the last quarter. Marshall Wace LLP purchased a new position in 908 Devices in the second quarter valued at approximately $229,000. Finally, Squarepoint Ops LLC purchased a new position in 908 Devices in the second quarter valued at approximately $250,000. 88.06% of the stock is currently owned by hedge funds and other institutional investors.

908 Devices Stock Down 0.9 %

908 Devices stock traded down $0.03 during mid-day trading on Tuesday, hitting $3.44. The company had a trading volume of 60,466 shares, compared to its average volume of 198,468. The stock has a market cap of $118.63 million, a price-to-earnings ratio of -3.21 and a beta of 0.97. 908 Devices Inc. has a 1 year low of $3.24 and a 1 year high of $12.51. The business has a fifty day moving average of $3.78 and a 200 day moving average of $5.09.

908 Devices (NASDAQ:MASS - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.34) by $0.02. The company had revenue of $14.05 million for the quarter, compared to analyst estimates of $13.69 million. 908 Devices had a negative net margin of 72.10% and a negative return on equity of 22.47%. Equities analysts anticipate that 908 Devices Inc. will post -1.21 earnings per share for the current year.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.